To main content To main navigation

Steven de Jong

Professor of Preclinical and Translational Oncology Profile

Professor of Preclinical and Translational Oncology

Contact information

Discover our research

Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.

2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

2023, Journal of experimental & clinical cancer research

All publications

- Supervision of PhD student Rinskje TjeerdsmaMarcel van Vugt (Supervisor), Steven de Jong (Supervisor) 2023 → 2027 Supervision and examination of PhD students of the UG > Academic
- Serine auxotrophy: a novel metabolic vulnerability of platinum resistant ovarian cancers?Steven de Jong (Examiner) 1-Dec-2022 Examination, teaching and supervision external institution > Academic
- Targeting ovarian clear cell cancerSteven de Jong (Invited speaker) 1-Dec-2022 Academic presentation > Academic
- Precision Medicine: Elke tumor z’n eigen achilleshielSteven de Jong (Invited speaker) 26-Aug-2022 Professional or public presentation > Popular
- EuroPDX workshop 2022Steven de Jong (Organiser) 27-Jun-2022 → 29-Jun-2022 Organising and contributing to an event > Professional
All activities

Contact

Send a message